Core Viewpoint - The company is focusing on consumer engagement and innovation to enhance product development and meet the needs of children, particularly through direct interaction with young users during product testing events [1][3]. Group 1: Company Overview - Founded in September 2003 in Changsha, Hunan, the company became the first infant formula company listed on the Hong Kong Stock Exchange in October 2009 (stock code 1717.HK) [5]. - The company has established a complete global supply chain with 11 factories and sells products in over 60 countries and regions, focusing on high-end dairy and nutritional products [5]. - The company has developed a comprehensive nutrition care system covering infant formula, health foods, specialized medical foods, and personalized nutrition products [5]. Group 2: Recent Performance - In 2024, the company achieved a revenue of approximately RMB 7.402 billion, representing a year-on-year growth of 0.3%, while the profit attributable to equity holders increased by 35.3% to approximately RMB 236 million [6]. - The company has demonstrated resilience in revenue and profit growth despite external economic challenges [6]. Group 3: Innovation and Product Development - The company emphasizes continuous innovation across its entire supply chain to drive internal growth and high-quality development [6]. - In May of this year, the company launched four new sheep milk raw materials, filling market gaps in hydrolyzed proteins and lactoferrin, which will be applied in various product lines [6]. - The company aims to provide more high-quality, personalized, convenient, and intelligent dairy products to its users in the future [6].